PMC:7127386 / 957-1294 JSON TXT

Annnotations TAB JSON ListView MergeView

Id	Subject	Object	Predicate	Lexical cue	tao:has_database_id
45	201-211	Species	denotes	SARS-CoV-2	Tax:2697049
46	181-191	Chemical	denotes	Remdesivir	MESH:C000606551
47	227-234	CellLine	denotes	Vero-E6	CVCL:0574
51	304-314	Species	denotes	SARS-CoV-2	Tax:2697049
52	267-276	Chemical	denotes	Lopinavir	MESH:D061466
53	285-294	Chemical	denotes	ritonavir	MESH:D019438

Id	Subject	Object	Predicate	Lexical cue	fma_id
T2	106-112	Body_part	denotes	plasma	http://purl.org/sig/ont/fma/fma62970
T3	235-240	Body_part	denotes	cells	http://purl.org/sig/ont/fma/fma68646

Id	Subject	Object	Predicate	Lexical cue	mondo_id
T5	201-209	Disease	denotes	SARS-CoV	http://purl.obolibrary.org/obo/MONDO_0005091
T6	304-312	Disease	denotes	SARS-CoV	http://purl.obolibrary.org/obo/MONDO_0005091

Id	Subject	Object	Predicate	Lexical cue
T4	106-112	http://purl.obolibrary.org/obo/UBERON_0001969	denotes	plasma
T5	227-240	http://purl.obolibrary.org/obo/CLO_0051719	denotes	Vero-E6 cells

Id	Subject	Object	Predicate	Lexical cue	chebi_id
T13	267-276	Chemical	denotes	Lopinavir	http://purl.obolibrary.org/obo/CHEBI_31781
T14	285-294	Chemical	denotes	ritonavir	http://purl.obolibrary.org/obo/CHEBI_45409

Id	Subject	Object	Predicate	Lexical cue
T8	2-165	Sentence	denotes	Combinational therapy may help to reduce the effective concentration of compounds below the therapeutic plasma concentrations and provide better clinical benefits.
T9	167-177	Sentence	denotes	Highlights
T10	178-263	Sentence	denotes	• Remdesivir inhibits SARS-CoV-2 replication in Vero-E6 cells with EC50 at 23.15 μM.

Id	Subject	Object	Predicate	Lexical cue
T24	74-83	CHEBI:36357;CHEBI:36357	denotes	compounds
T25	106-112	UBERON:0001969	denotes	plasma
T26	181-191	DG_28	denotes	Remdesivir
T27	201-211	SP_7	denotes	SARS-CoV-2
T28	212-223	GO:0006260	denotes	replication
T29	227-231	CL_6	denotes	Vero
T30	267-276	DG_23	denotes	Lopinavir
T31	285-294	DG_30	denotes	ritonavir
T32	304-314	SP_7	denotes	SARS-CoV-2
T33	315-326	GO:0006260	denotes	replication
T65617	74-83	CHEBI:36357;CHEBI:36357	denotes	compounds
T6727	106-112	UBERON:0001969	denotes	plasma
T54351	181-191	DG_28	denotes	Remdesivir
T83036	201-211	SP_7	denotes	SARS-CoV-2
T96493	212-223	GO:0006260	denotes	replication
T85588	227-231	CL_6	denotes	Vero
T81617	267-276	DG_23	denotes	Lopinavir
T3856	285-294	DG_30	denotes	ritonavir
T86607	304-314	SP_7	denotes	SARS-CoV-2
T41304	315-326	GO:0006260	denotes	replication
T83525	123-133	DG_28	denotes	ions and p
T59770	135-142	DG_28	denotes	vide be
T32737	147-154	CHEBI:50266;CHEBI:50266	denotes	clinica
T67513	158-168	CHEBI:22260;CHEBI:22260	denotes	nefits. H
T44435	226-237	NCBITaxon:4894	denotes	Vero-E6 ce
T45810	239-254	NCBITaxon:7656	denotes	s with EC50 at
T98605	260-275	NCBITaxon:11118	denotes	μM. • Lopinavi